ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 107 filers reported holding ADMA BIOLOGICS INC in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $18,756,948 | +34.9% | 5,239,371 | +39.0% | 0.00% | +100.0% |
Q2 2023 | $13,905,462 | -5.9% | 3,768,418 | -15.6% | 0.00% | -50.0% |
Q1 2023 | $14,782,797 | +18.0% | 4,466,102 | +38.3% | 0.00% | +100.0% |
Q4 2022 | $12,525,945 | +118.6% | 3,228,336 | +36.9% | 0.00% | 0.0% |
Q3 2022 | $5,729,000 | +236.8% | 2,357,621 | +174.5% | 0.00% | – |
Q2 2022 | $1,701,000 | +608.8% | 858,763 | +553.6% | 0.00% | – |
Q1 2022 | $240,000 | -45.0% | 131,386 | -57.6% | 0.00% | – |
Q4 2021 | $436,000 | -39.5% | 310,029 | -51.4% | 0.00% | – |
Q3 2021 | $721,000 | +7.0% | 638,534 | +51.8% | 0.00% | – |
Q2 2021 | $674,000 | +0.6% | 420,606 | +10.5% | 0.00% | – |
Q1 2021 | $670,000 | +67.1% | 380,576 | +85.0% | 0.00% | – |
Q4 2020 | $401,000 | -32.7% | 205,724 | -17.5% | 0.00% | – |
Q3 2020 | $596,000 | -0.5% | 249,212 | +21.8% | 0.00% | – |
Q2 2020 | $599,000 | +227.3% | 204,529 | +222.9% | 0.00% | – |
Q1 2020 | $183,000 | -57.4% | 63,333 | -41.0% | 0.00% | – |
Q4 2019 | $430,000 | +69.3% | 107,306 | +88.1% | 0.00% | – |
Q3 2019 | $254,000 | +85.4% | 57,052 | +61.7% | 0.00% | – |
Q2 2019 | $137,000 | -7.4% | 35,282 | -9.6% | 0.00% | – |
Q1 2019 | $148,000 | -3.9% | 39,014 | -39.6% | 0.00% | – |
Q4 2018 | $154,000 | -63.2% | 64,552 | -4.1% | 0.00% | – |
Q3 2018 | $418,000 | +92.6% | 67,317 | +39.7% | 0.00% | – |
Q2 2018 | $217,000 | +267.8% | 48,180 | +270.3% | 0.00% | – |
Q1 2018 | $59,000 | +391.7% | 13,011 | +244.8% | 0.00% | – |
Q4 2017 | $12,000 | -20.0% | 3,774 | -22.4% | 0.00% | – |
Q3 2017 | $15,000 | -51.6% | 4,863 | -41.0% | 0.00% | – |
Q2 2017 | $31,000 | -61.2% | 8,237 | -50.0% | 0.00% | – |
Q1 2017 | $80,000 | -4.8% | 16,474 | 0.0% | 0.00% | – |
Q4 2016 | $84,000 | +35.5% | 16,474 | +93.0% | 0.00% | – |
Q3 2016 | $62,000 | +12.7% | 8,537 | -6.7% | 0.00% | – |
Q2 2016 | $55,000 | -27.6% | 9,152 | -3.1% | 0.00% | – |
Q1 2016 | $76,000 | +46.2% | 9,441 | +46.3% | 0.00% | – |
Q4 2015 | $52,000 | 0.0% | 6,452 | +4.9% | 0.00% | – |
Q3 2015 | $52,000 | +20.9% | 6,152 | +32.9% | 0.00% | – |
Q2 2015 | $43,000 | +290.9% | 4,628 | +297.3% | 0.00% | – |
Q1 2015 | $11,000 | +57.1% | 1,165 | +74.9% | 0.00% | – |
Q4 2014 | $7,000 | – | 666 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Velan Capital Investment Management LP | 4,000,000 | $13,240,000 | 11.29% |
Stonepine Capital Management, LLC | 7,661,690 | $25,360,194 | 8.50% |
Altium Capital Management LP | 2,870,000 | $9,499,700 | 5.27% |
Caligan Partners LP | 1,662,613 | $5,503,249 | 3.84% |
AWM Investment Company, Inc. | 6,015,000 | $19,909,650 | 2.69% |
Perceptive Advisors | 11,900,255 | $39,389,844 | 1.16% |
EAM Investors, LLC | 1,035,752 | $3,428,339 | 0.67% |
OBERWEIS ASSET MANAGEMENT INC/ | 1,169,500 | $3,871,045 | 0.60% |
Magnetar Financial LLC | 7,074,722 | $23,417,330 | 0.46% |
Virtus ETF Advisers LLC | 83,925 | $277,792 | 0.15% |